Technical Analysis for NVTA - Invitae Corporation

Grade Last Price % Change Price Change
grade B 24.33 3.31% 0.78
NVTA closed down 7.76 percent on Friday, March 22, 2019, on 1.82 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical NVTA trend table...

Date Alert Name Type % Chg
Mar 22 Bearish Engulfing Bearish 3.31%
Mar 22 Slingshot Bullish Bullish Swing Setup 3.31%
Mar 22 Wide Bands Range Expansion 3.31%
Mar 22 Overbought Stochastic Strength 3.31%
Mar 21 New 52 Week Closing High Bullish -4.70%
Mar 21 New 52 Week High Strength -4.70%
Mar 21 Wide Bands Range Expansion -4.70%
Mar 21 Overbought Stochastic Strength -4.70%
Mar 21 Up 3 Days in a Row Strength -4.70%
Mar 20 New 52 Week Closing High Bullish -2.84%

Older signals for NVTA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Invitae Corporation processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for physicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities. The company's product is an assay of 216 genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, and other hereditary conditions comprising 85 various genetic disorders and 17 targeted panels. It also solutions that enable sharing of genetic information consisting of Invitae Family History Tool, a Web or iPad application, which provides family history; and Clinvitae, a Web property that allows physicians or patients to look up individual genes and variants in order to find out additional genetic information. It operates in the United States, Israel, and internationally. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Medicine Cancer Biology Genetics Medical Genetics Medical Tests Neurological Disorders Molecular Diagnostics Software Tools Genetic Disorders Cardiovascular Disorders Genetic Disorder Neurology
Is NVTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 25.73
52 Week Low 4.35
Average Volume 1,836,690
200-Day Moving Average 13.1695
50-Day Moving Average 17.694
20-Day Moving Average 21.9895
10-Day Moving Average 23.928
Average True Range 1.2912
ADX 58.85
+DI 29.6027
-DI 10.9169
Chandelier Exit (Long, 3 ATRs ) 21.8564
Chandelier Exit (Short, 3 ATRs ) 21.6136
Upper Bollinger Band 26.1446
Lower Bollinger Band 17.8344
Percent B (%b) 0.69
BandWidth 37.791673
MACD Line 2.1299
MACD Signal Line 2.074
MACD Histogram 0.0559
Fundamentals Value
Market Cap 1.03 Billion
Num Shares 43.5 Million
EPS -2.73
Price-to-Earnings (P/E) Ratio -8.63
Price-to-Sales 9.34
Price-to-Book 5.59
PEG Ratio -0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.90
Resistance 3 (R3) 27.25 26.49 26.34
Resistance 2 (R2) 26.49 25.64 26.31 26.15
Resistance 1 (R1) 25.02 25.11 24.64 24.67 25.97
Pivot Point 24.26 24.26 24.07 24.08 24.26
Support 1 (S1) 22.79 23.41 22.41 22.44 21.13
Support 2 (S2) 22.03 22.88 21.85 20.95
Support 3 (S3) 20.56 22.03 20.76
Support 4 (S4) 20.21